Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of the Drugs (Prices Control) Order and monitoring of prices of controlled and decontrolled drugs. In another notification, NPPA said it has also “fixed/ revised ceiling prices of 32 scheduled formulations packs of IV Fluids”. Ceiling prices of these formulations have been re-fixed under modified categories such as glass, non-glass and separate ceiling prices for specific manufacturers of non-glass with special features,” NPPA added. NPPA said manufacturers not complying with the ceiling price will be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Price Control) Order, 2013. The government had notified DPCO, 2013, which covers 680 formulations, with effect from May 15, 2014, replacing the 1995 order that regulated prices of only 74 bulk drugs.

Source: Hindustan Times June 27, 2016 15:31 UTC